Bengaluru, 26th May, 2026. For a long time, the human heart has been compared to a clock—a relentless, ticking engine of life. But when the heart’s valves begin to fail, that steady rhythm turns into a race against time.
For two elderly men in India, ages 80 and 69, the clock was ticking dangerously fast. Both suffered from pure native aortic regurgitation, a cruel condition where the heart’s main valve fails to close properly. Instead of pumping life-giving blood forward into the body, the valve lets it leak backward into the heart. The organ works twice as hard for half the result, gradually exhausting itself.
For patients like them, the traditional answer was open-heart surgery—a brutal, hours-long marathon of cracking open the chest. But because of their advanced age and fragile health, the operating table was a risk they might not survive. Left untreated, the statistics were grim: a 50% chance of survival past two years. They were caught in a medical no-man’s-land.
Then, history was made at Narayana Health City in Bengaluru.
The Uncharted Defies the Odds
Transcatheter Aortic Valve Implantation (TAVI) wasn’t new, but using it for this specific condition was considered a medical mountain yet unclimbed in India. In normal TAVI procedures, doctors use the heart’s own hardened, calcified deposits to anchor a new artificial valve in place. But pure aortic regurgitation leaves no calcium behind. There was nothing for a standard valve to grip onto; it was like trying to anchor a ship in shifting sand.
Where previous non-dedicated devices had failed or yielded unpredictable results, a breakthrough was needed. Enter Dr. Suraj Narasimhan, Senior Consultant Cardiologist and Structural Intervention Specialist, and his elite multidisciplinary heart team.
Recognizing that their patients’ lives hung in the balance, Narayana Health City fought through bureaucratic red tape to secure special government approvals, importing a revolutionary, dedicated device engineered specifically for this anatomical puzzle: the HANCHOR valve system.
Forty-Five Minutes to a New Life
The atmosphere in the cardiac catheterization laboratory was charged with focused intensity. There would be no major incisions, no heart-lung machines, and no cracked ribs.
Through a puncture no larger than a pen tip in the patient’s thigh, Dr. Narasimhan threaded the HANCHOR valve up through the femoral artery, guiding it meticulously toward the heart. In the ultimate test of medical precision, the valve was deployed into the non-calcified, leaking gateway. It gripped perfectly, expanding to create a flawless, watertight seal.
The procedure took less than an hour. Where open-heart surgery demands weeks of painful intensive care, this non-surgical marvel allowed both men to be back on their feet within 12 hours, and safely discharged to their families in just 48 hours.
“This procedure delivers what previously required open-heart surgery, through a small puncture in the thigh, in under an hour, with patients back on their feet within 12 hours,” said Dr. Suraj Narasimhan. “It is a genuine turning point… and we are proud that this chapter was written at Narayana Health City.”
A New Dawn for Cardiac Care
With this single landmark achievement, Narayana Health City—already a beacon of cardiac excellence with over 750 TAVI procedures completed—has opened a door that was once firmly shut.
This isn’t just a victory of medicine and technology; it is a victory of human empathy and determination. It means that for thousands of aging mothers, fathers, and grandparents across India who were once told they were “out of options,” there is now a second chance.
The clock is still ticking for patients with heart disease—but thanks to this medical breakthrough, the rhythm is now one of hope.
